Author

E. K. Amason

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

E. S. Krystofiak· 1 shared J. C. Rathmell· 1 shared K. E. Beckermann· 1 shared M. Landis· 1 shared M. M. Wolf· 1 shared R. A. Hongo· 1 shared W. A. Brown· 1 shared W. K. Rathmell· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. S. Krystofiak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma

Z. A. Bacigalupa, W. A. Brown, E. S. Krystofiak, M. M. Wolf, R. A. Hongo, M. Landis, E. K. Amason, K. E. Beckermann, J. C. Rathmell, W. K. Rathmell

This study shows ACSS2 promotes HIF-2 stability by preventing its interaction with MUL1, and inhibiting ACSS2 reduces HIF-2 levels and suppresses ccRCC growth.

bioRxiv · Apr 21, 2022 · PreprintCancer Biology